TCL Archive In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents May 8, 1981
TCL Archive Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance December 13, 1996
TCL Archive NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed July 9, 1976
TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009